45 Although self-monitoring of blood glucose levels may be helpful in patients who are ill or symptomatic or in patients with newly diagnosed type 2 diabetes, it does not result in lower glycemic levels and should not be used on its own to guide treatment
In this blog, we'll delve into how to effectively communicate with your doctor about starting GLP-1 therapy, ensuring that you're empowered and informed throughout the process
Any compounding pharmacy or outsourcing facility that continues preparing tirzepatide products faces potential FDA enforcement action, including warning letters, injunctions, and criminal prosecution in severe cases
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Long-Term Risks: What We Don't Know This is arguably the most vital part of this guide
Pharmacists are well suited to advocate for optimal patient care by recommending appropriate agents on the basis of patient-specific considerations and providing appropriate education to people living with T2D